Epigenetic Changes of the Immune System with Role in Tumor Development
- PMID: 30178253
- DOI: 10.1007/978-1-4939-8751-1_11
Epigenetic Changes of the Immune System with Role in Tumor Development
Abstract
Tumor development is closely related to chronic inflammation and to evasion of immune defense mechanisms by neoplastic cells. The mediators of the inflammatory process as well as proteins involved in immune response or immune response evasion can be subject to various epigenetic changes such as methylation, acetylation, or phosphorylation. Some of these, such as cytokine suppressors, are undergoing repression through epigenetic changes, and others such as cytokines or chemokines are undergoing activation through epigenetic changes, both modifications having as a result tumor progression. The activating changes can affect the receptor molecules involved in immune response and these promote inflammation and subsequently tumor development while the inactivating changes seem to be related to the tumor regression process. The proteins involved in antigen presentation, and, therefore in immune response escape, such as classical HLA proteins and related APM (antigen presentation machinery) with their epigenetic changes contribute to the tumor development process, either to tumor progression or regression, depending on the immune effector cells that are in play.
Keywords: 5-aza-2-deoxycytidine; APM; Acetylation; CIITA; Cancer; Chemokines; Cytokines; Epigenetics; HDAC inhibitors; HLA; Immune escape; Inflammation; Methylation; NK cells; Nonclassical HLA; SOCS; TLR.
Similar articles
-
Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies.Mediators Inflamm. 2015;2015:201703. doi: 10.1155/2015/201703. Epub 2015 Mar 1. Mediators Inflamm. 2015. PMID: 25814785 Free PMC article. Review.
-
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.Oncogene. 2008 Oct 6;27(45):5869-85. doi: 10.1038/onc.2008.273. Oncogene. 2008. PMID: 18836468 Free PMC article. Review.
-
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review.
-
Interplay Between Inflammation and Epigenetic Changes in Cancer.Prog Mol Biol Transl Sci. 2016;144:69-117. doi: 10.1016/bs.pmbts.2016.09.002. Epub 2016 Oct 7. Prog Mol Biol Transl Sci. 2016. PMID: 27865469 Review.
-
Role of epigenetics in inflammation-associated diseases.Subcell Biochem. 2013;61:627-57. doi: 10.1007/978-94-007-4525-4_27. Subcell Biochem. 2013. PMID: 23150270 Review.
Cited by
-
Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma.Front Genet. 2022 Nov 23;13:986325. doi: 10.3389/fgene.2022.986325. eCollection 2022. Front Genet. 2022. PMID: 36506326 Free PMC article.
-
The mechanisms on evasion of anti-tumor immune responses in gastric cancer.Front Oncol. 2022 Nov 10;12:943806. doi: 10.3389/fonc.2022.943806. eCollection 2022. Front Oncol. 2022. PMID: 36439472 Free PMC article. Review.
-
Targeting the chromatin structural changes of antitumor immunity.J Pharm Anal. 2024 Apr;14(4):100905. doi: 10.1016/j.jpha.2023.11.012. Epub 2023 Nov 29. J Pharm Anal. 2024. PMID: 38665224 Free PMC article. Review.
-
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.Trends Cancer. 2021 Dec;7(12):1089-1101. doi: 10.1016/j.trecan.2021.07.006. Epub 2021 Sep 3. Trends Cancer. 2021. PMID: 34489208 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials